⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513766 | 0.94 | — | — | |
| SCHEMBL1763990 | 0.78 | — | — | |
| SCHEMBL1603737 | 0.75 | — | — | |
| SCHEMBL9494298 | 0.72 | — | — | |
| SCHEMBL1004709 | 0.69 | — | — | |
| SCHEMBL994101 | 0.69 | — | — | |
| SCHEMBL26187546 | 0.67 | — | — | |
| SCHEMBL9494293 | 0.66 | — | — | |
| SCHEMBL1763993 | 0.64 | — | — | |
| SCHEMBL7858703 | 0.64 | TSHR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717779-A2 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TriLink BioTechnologies, LLC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4276189-B1 | INITIATING CAPPED OLIGONUCLEOTIDE PRIMERS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES LLC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4424835-B1 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES LLC (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4658664-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2025-12-10 | — | — | EP | disclosed |
| US-20250171489-A1 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES, LLC (US) | 2025-05-29 | — | — | US | disclosed |
| US-12258369-B2 | Compositions and methods for synthesizing 5′-capped RNAs | TRILINK BIOTECHNOLOGIES, LLC (US) | 2025-03-25 | — | — | US | disclosed |
| US-20240383938-A1 | PHOSPHOROAMIDATE ESTERS, AND USE AND SYNTHESIS THEREOF | ROCHE SEQUENCING SOLUTIONS INC (US) | 2024-11-21 | — | — | US | disclosed |
| US-12103944-B2 | Compositions and methods for synthesizing 5′-capped RNAs | TRILINK BIOTECHNOLOGIES, LLC (US) | 2024-10-01 | — | — | US | disclosed |
| EP-4424835-A2 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TriLink BioTechnologies, LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024160895-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2024-08-08 | — | — | WO | disclosed |
| US-20120264924-A1 | Glycorandomization and Production of Novel Novobiocin Analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-8198419-B2 | Glycorandomization and production of novel erythromycin analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-06-12 | — | — | US | disclosed |
| US-20110124850-A1 | Glycorandomization and Production of Novel Vancomycin Analogs | THORSON JON | 2011-05-26 | — | — | US | disclosed |
| EP-1138782-B1 | Multiplex sequence variation analysis of DNA samples by mass spectrometry | BRUKER DALTONIK GMBH (DE) | 2010-10-20 | — | — | EP | disclosed |
| US-20090023594-A1 | REAGENTS FOR LABELLING NUCLEIC ACIDS AND USES THEREOF | EXIQON A/S (DK) | 2009-01-22 | — | — | US | disclosed |
| US-20080268504-A1 | Glycorandomization and Production of Novel Vancomycin Analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-10-30 | — | — | US | disclosed |
| US-7348309-B2 | Glycorandomization and production of novel vancomycin analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-03-25 | — | — | US | disclosed |
| US-20040259228-A1 | Glycorandomization and production of novel vancomycin analogs | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-12-23 | — | — | US | disclosed |
| US-20010038070-A1 | Multiplex sequence variation analysis of DNA samples by mass spectrometry | BRUKER SAXONIA ANALYTIK GMBH (DE) | 2001-11-08 | — | — | US | disclosed |
| EP-1138782-A2 | Multiplex sequence variation analysis of DNA samples by mass spectrometry | BRUKER-SAXONIA ANALYTIK GMBH (DE) | 2001-10-04 | — | — | EP | disclosed |